PBS additions for cancer and epilepsy Tens of thousands of patients each year are set to benefit from several first-time additions, including Zyamis and Tecentriq SC.
Nurse practitioner Jardiance prescribing greenlit It can now be prescribed by NPs as an initial or continuing therapy for chronic heart failure, but the change raises red flags with the RACGP.
Wegovy launches in Australia The manufacturer assured GPs supply planning has been its priority amid critical Ozempic shortages, but concerns remain over Wegovy’s availability.
Diabetes medication restrictions incoming More red tape is on the way after the PBAC recommended GPs gain additional approval before starting patients on Qtern 5/10.
Cystic fibrosis medication expanded on PBS Doctors can soon prescribe subsidised Trikafta to children earlier, in a ‘lifechanging’ move set to save families $250,000 each year.
Olaparib and anifrolumab added to PBS The treatments for breast cancer and lupus have now been added to the scheme, alongside medicines for leukaemia and insomnia.
PBS restrictions placed on diabetes medicines GPs now need to gain additional approval prior to starting patients on all GLP-1 RAs, including semaglutide.
Is prescription affordability impacting hospitalisations? Research has revealed patients unable to pay for medication are ending up in hospitals, as doctors call for cost-of-living relief.
Study questions Paxlovid’s COVID-19 ‘usefulness’ Researchers say the antiviral does little to reduce symptom duration for some vaccinated patients, but still recommended its use for the vulnerable.
Opioid prescriptions are down – but is dependence? While PBS listing revisions have potentially reduced opioid prescriptions, experts say more active treatment is required to reduce harm.